[News Brief] Agilus and Lucence Partner to Expand Molecular Cancer Testing in India
Agilus Diagnostics and Lucence announced a strategic partnership on 24 February 2025 to integrate liquid biopsy technology into Agilus’ laboratory…
Press Release
[News Brief] Lucence Demonstrates Improved Cancer Diagnostic Yield at ASCO 2025
Lucence presented clinical data at the 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago. The studies evaluate a…
[News Brief] Mirxes Lists on HKEX as Southeast Asia’s First Biotech Unicorn
Mirxes listed on the Hong Kong Stock Exchange Main Board on 23 May 2025, reaching a market capitalisation of HK$8.29…
[News Brief] Mirxes and Former PM Hatoyama Launch Gastric Screening Initiative
Former Japanese Prime Minister Yukio Hatoyama launched a public health initiative on 23 July 2025 to provide 10,000 free gastric…
[News Brief] Mirxes Joined Hang Seng Composite Index to Boost Liquidity
Singapore-based RNA technology firm Mirxes joined the Hang Seng Composite Index last 8 September 2025. This inclusion, following the company’s…
[News Brief] Mirxes Obtains China NMPA Approval for Gastric Cancer Blood Test
Mirxes has received regulatory approval from China’s National Medical Products Administration (NMPA) for GASTROClear, a blood-based diagnostic test. The approval…
[News Brief] R-Bridge Provides $40M Financing to Mirxes to Expand Cancer Diagnostics
R-Bridge Healthcare Fund has provided $40 million in synthetic royalty-backed financing to Singapore-based Mirxes. The capital supports the global commercialisation…
[News Brief] Circle DNA Launches Whole Exome Genetic Test with JD.com
Circle DNA, a joint venture between Berry Genomics and Prenetics, launched a consumer genetic test in China on April 22,…